These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18452216)

  • 1. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.
    Nilsson B; Andersson A; Ahlman H
    J Surg Oncol; 2008 Sep; 98(3):145-6. PubMed ID: 18452216
    [No Abstract]   [Full Text] [Related]  

  • 2. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
    Hohenberger P
    Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surgical treatment of an advanced GIST the age of imatinib].
    Fernández JA; Parrilla P
    Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib adjuvant therapy after surgical excision of gastrointestinal stromal tumour.
    Prescrire Int; 2011 Feb; 20(113):38. PubMed ID: 21488587
    [No Abstract]   [Full Text] [Related]  

  • 5. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
    Yoon SS; Tanabe KK
    Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expert consensus on surgical treatment for gastrointestinal stromal tumors].
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):947-8. PubMed ID: 18478940
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour.
    Abdulkader I; Cameselle-Teijeiro J; Forteza J
    Histopathology; 2005 Apr; 46(4):470-2. PubMed ID: 15810964
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant gastrointestinal stromal neoplasm.
    Jovine E; Biolchini F; Lerro FM; Mastrangelo L; Martuzzi F
    Surgery; 2006 Nov; 140(5):832-4. PubMed ID: 17084730
    [No Abstract]   [Full Text] [Related]  

  • 9. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
    Chacón M; Roca E; Huertas E; Loria FS; Domenechini E
    J Clin Oncol; 2005 Mar; 23(7):1580-2. PubMed ID: 15735135
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of gastrointestinal stromal tumors--initial experience.
    Lupaşcu C; Andronic D; Moldovanu R; Târcoveanu E; Georgescu S; Ferariu D
    Chirurgia (Bucur); 2010; 105(5):657-62. PubMed ID: 21141090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
    Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
    Ryu MH; Kang WK; Bang YJ; Lee KH; Shin DB; Ryoo BY; Roh JK; Kang JH; Lee H; Kim TW; Chang HM; Park JO; Park YS; Kim TY; Kim MK; Lee WK; Kang HJ; Kang YK
    Oncology; 2009; 76(5):326-32. PubMed ID: 19307738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
    Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
    Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
    Fiorentini G; Bernardeschi P; De Simone M; Rossi S; Dentico P; Biancalani M; Scuderi S; Vaira M; Palomba A
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):13-6. PubMed ID: 16767899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastrointestinal stromal tumors: case reports and review of the literature].
    Bronzino P; Colombini M; Ferro A; Gambetta G; Gennaro M; Ivaldi L; Revetria P
    G Chir; 2008; 29(1-2):33-7. PubMed ID: 18252146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors?
    Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS
    Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of advanced gastrointestinal stromal tumor: a marriage of targeted therapy and surgery?
    DeMatteo RP
    Ann Surg Oncol; 2007 Jan; 14(1):1-2. PubMed ID: 16957967
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
    Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
    Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.